Literature DB >> 19519197

Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy.

Bs Dwarakanath, Viney Jain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19519197     DOI： 10.2217/fon.09.44

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  49 in total

1.  Regulation of Serine-Threonine Kinase Akt Activation by NAD+-Dependent Deacetylase SIRT7.

Authors:  Jia Yu; Bo Qin; Fengying Wu; Sisi Qin; Somaira Nowsheen; Shan Shan; Jacqueline Zayas; Huadong Pei; Zhenkun Lou; Liewei Wang
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

2.  Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells.

Authors:  Yuanyuan Cui; Nagalakshmi Nadiminty; Chengfei Liu; Wei Lou; Chad T Schwartz; Allen C Gao
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

Review 3.  Manipulation of Glucose and Hydroperoxide Metabolism to Improve Radiation Response.

Authors:  John M Floberg; Julie K Schwarz
Journal:  Semin Radiat Oncol       Date:  2019-01       Impact factor: 5.934

4.  A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis.

Authors:  Xiao Yang; Yidong Cheng; Pengchao Li; Jun Tao; Xiaheng Deng; Xiaolei Zhang; Min Gu; Qiang Lu; Changjun Yin
Journal:  Tumour Biol       Date:  2014-09-30

5.  Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.

Authors:  Gang Cheng; Jacek Zielonka; Brian P Dranka; Donna McAllister; A Craig Mackinnon; Joy Joseph; Balaraman Kalyanaraman
Journal:  Cancer Res       Date:  2012-03-19       Impact factor: 12.701

6.  Inhibition of mTORC1 signaling sensitizes hepatocellular carcinoma cells to glycolytic stress.

Authors:  Xin Zhao; Peng Jiang; Xiang Deng; Zhonghu Li; Feng Tian; Fei Guo; Xiaowu Li; Shuguang Wang
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

7.  Targeting glucose metabolism in cancer: new class of agents for loco-regional and systemic therapy of liver cancer and beyond?

Authors:  Lynn Jeanette Savic; Julius Chapiro; Gregor Duwe; Jean-François Geschwind
Journal:  Hepat Oncol       Date:  2016-01-01

8.  Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response.

Authors:  Marie Bénéteau; Barbara Zunino; Marie A Jacquin; Ophélie Meynet; Johanna Chiche; Ludivine A Pradelli; Sandrine Marchetti; Aurore Cornille; Michel Carles; Jean-Ehrland Ricci
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

Review 9.  Targeting regulatory T cells for improving cancer therapy: Challenges and prospects.

Authors:  Bilikere S Dwarakanath; Abdullah Farooque; Seema Gupta
Journal:  Cancer Rep (Hoboken)       Date:  2018-05-15

Review 10.  Heterogeneity of glycolysis in cancers and therapeutic opportunities.

Authors:  Marc O Warmoes; Jason W Locasale
Journal:  Biochem Pharmacol       Date:  2014-08-02       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.